Drugs that contain Sodium Zirconium Cyclosilicate
1. Drug name - LOKELMA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US10413569 | ASTRAZENECA | Microporous zirconium silicate for the treatment of hyperkalemia |
Feb, 2032
(9 years from now) | |
| US8802152 | ASTRAZENECA | Microporous zirconium silicate for the treatment of hyperkalemia |
Apr, 2032
(9 years from now) | |
| US10695365 | ASTRAZENECA | Microporous zirconium silicate for the treatment of hyperkalemia |
Oct, 2033
(11 years from now) | |
| US8877255 | ASTRAZENECA | Microporous zirconium silicate for the treatment of hyperkalemia |
Oct, 2033
(11 years from now) | |
| US9913860 | ASTRAZENECA | Microporous zirconium silicate for the treatment of hyperkalemia |
Oct, 2033
(11 years from now) | |
| US10300087 | ASTRAZENECA | Extended use zirconium silicate compositions and methods of use thereof |
Oct, 2035
(13 years from now) | |
| US9592253 | ASTRAZENECA | Extended use zirconium silicate compositions and methods of use thereof |
Oct, 2035
(13 years from now) | |
| CN103534209A | ASTRAZENECA | Microporous Zirconium Silicate For The Treatment Of Hyperkalemia |
Mar, 2019
(3 years ago) | |
| CN106385795A | ASTRAZENECA | Microporous Zirconium Silicate For Treating Hyperpotassaemia |
Jul, 2019
(3 years ago) | |
| CN104797263A | ASTRAZENECA | Microporous Zirconium Silicate For Treating Hyperpotassaemia |
Oct, 2033
(11 years from now) | |
| CN104797263B | ASTRAZENECA | For Curing Hyperpotassaemia Microporous Zirconium Silicate |
Oct, 2033
(11 years from now) | |
| CN106170283A | ASTRAZENECA | Micro-Pore Zirconium Silicate For Treating Hyperkalemia |
Nov, 2034
(12 years from now) | |
| CN106170283B | ASTRAZENECA | For Microporous Zirconium Silicate Of Curing Hyperpotassaemia |
Nov, 2034
(12 years from now) | |
| CN108137620A | ASTRAZENECA | Expand The Using Zirconium Silicate Composition And Use Method Thereof |
Oct, 2036
(14 years from now) | |
| CN108137620B | ASTRAZENECA | Method For Expanding Use Of Zirconium Silicate Composition And Method Of Using The Same |
Oct, 2036
(14 years from now) | |
| IN394538B | ASTRAZENECA | A Cation Exchange Composition Comprising A Zirconium Silicate |
Oct, 2036
(14 years from now) | |
| IN201817010535A | ASTRAZENECA | Extended Use Zirconium Silicate Compositions And Methods Of Use Thereof |
Oct, 2036
(14 years from now) | |
| EP2673237B1 | ASTRAZENECA | Use Of A Zirconium Silicate For The Treatment Of Hyperkalemia |
Feb, 2032
(9 years from now) | |
| EP2673237A2 | ASTRAZENECA | Use Of A Zirconium Silicate For The Treatment Of Hyperkalemia |
Feb, 2032
(9 years from now) | |
| EP2673237A4 | ASTRAZENECA | Microporous Zirconium Silicate For The Treatment Of Hyperkalemia |
Feb, 2032
(9 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8808750 | ASTRAZENECA | Microporous zirconium silicate for the treatment of hyperkalemia |
Feb, 2032
(9 years from now) | |
| US9844567 | ASTRAZENECA | Microporous zirconium silicate for the treatment of hyperkalemia |
Feb, 2032
(9 years from now) | |
| US9861658 | ASTRAZENECA | Microporous zirconium silicate for the treatment of hyperkalemia |
Feb, 2032
(9 years from now) | |
| US10335432 | ASTRAZENECA | Microporous zirconium silicate for the treatment of hyperkalemia |
Feb, 2032
(9 years from now) | |
| US10398730 | ASTRAZENECA | Microporous zirconium silicate for the treatment of hyperkalemia |
Feb, 2032
(9 years from now) | |
Treatment: Treatment of hyperkalemia in adults
Dosage: FOR SUSPENSION;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 5GM/PACKET | FOR SUSPENSION;ORAL | Prescription |
| 10GM/PACKET | FOR SUSPENSION;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.